Education
About Us
Working with TipRanks
Follow Us
Assembly Biosciences (ASMB)
NASDAQ:ASMB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 28.52M | $ 7.16M | $ 0.00 | $ 6.25M | $ 79.11M |
| Gross Profit | $ 28.52M | $ -41.74M | $ -69.08M | $ 6.25M | $ -22.23M |
| Operating Income | $ -45.42M | $ -64.65M | $ -94.11M | $ -132.69M | $ -64.78M |
| EBITDA | $ -45.29M | $ -64.20M | $ -92.52M | $ -90.58M | $ -58.40M |
| Net Income | $ -40.18M | $ -61.23M | $ -93.09M | $ -129.85M | $ -62.15M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 112.08M | $ 130.25M | $ 91.61M | $ 146.63M | $ 216.41M |
| Total Assets | $ 119.17M | $ 136.82M | $ 101.79M | $ 191.06M | $ 283.25M |
| Total Debt | $ 3.09M | $ 2.34M | $ 3.46M | $ 6.48M | $ 10.13M |
| Net Debt | $ -35.26M | $ -17.50M | $ -48.95M | $ -39.15M | $ -49.31M |
| Total Liabilities | $ 85.81M | $ 95.73M | $ 19.13M | $ 22.13M | $ 42.68M |
| Stockholders' Equity | $ 33.36M | $ 41.10M | $ 82.66M | $ 168.93M | $ 240.58M |
| Cash Flow | |||||
| Free Cash Flow | $ -51.15M | $ 22.49M | $ -84.56M | $ -96.49M | $ -65.18M |
| Operating Cash Flow | $ -51.12M | $ 22.74M | $ -84.46M | $ -93.40M | $ -62.96M |
| Investing Cash Flow | $ 40.17M | $ -69.14M | $ 90.64M | $ 26.52M | $ 68.07M |
| Financing Cash Flow | $ 29.45M | $ 13.82M | $ 614.00K | $ 53.06M | $ 7.60M |